Zoletil 100 liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai suņiem un kaķiem
Zoletil 100 liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai suņiem un kaķiem
Authorised
- Tiletamine hydrochloride
- Zolazepam hydrochloride
Product identification
Medicine name:
Zoletil 100 liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai suņiem un kaķiem
Active substance:
- Tiletamine hydrochloride
- Zolazepam hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Tiletamine hydrochloride250.00/milligram(s)1.00Vial
-
Zolazepam hydrochloride250.00/milligram(s)1.00Vial
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Package description:
- Available only in Latvian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/07/1711
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 15/12/2025
Labelling
This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 15/12/2025
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 15/12/2025